These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1325234)

  • 21. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
    Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amniotic-fluid ingestion enhances the central analgesic effect of morphine.
    Di Pirro JM; Thompson AC; Kristal MB
    Brain Res Bull; 1991 Jun; 26(6):851-5. PubMed ID: 1933405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central glucagon antagonizes morphine- and stress-induced antinociception in the mouse.
    Malcolm DS; Amir S; Holaday JW
    NIDA Res Monogr; 1986; 75():371-4. PubMed ID: 3123953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
    Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of cyclosporine on morphine-induced antinociception in diabetic mice.
    Kamei J; Kawashima N; Suzuki T; Misawa M; Kasuya Y
    Neurosci Lett; 1993 Aug; 158(2):213-6. PubMed ID: 8233098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in beta-funaltrexamine-treated mice.
    Takemori AE; Portoghese PS
    J Pharmacol Exp Ther; 1987 Oct; 243(1):91-4. PubMed ID: 2822908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paradoxical analgesia produced by naloxone in diabetic mice is attributable to supersensitivity of delta-opioid receptors.
    Kamei J; Kawashima N; Kasuya Y
    Brain Res; 1992 Oct; 592(1-2):101-5. PubMed ID: 1450902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of diabetes on stress-induced analgesia in mice.
    Kamei J; Kawashima N; Ohhashi Y; Kasuya Y
    Brain Res; 1992 May; 580(1-2):180-4. PubMed ID: 1324087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide opioid antagonist separates peripheral and central opioid antitransit effects.
    Shook JE; Pelton JT; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1987 Nov; 243(2):492-500. PubMed ID: 2824748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for the modulation of spontaneous locomotor activity by higher serum glucose levels and/or spleen-derived factor(s) in diabetic mice.
    Kamei J; Saitoh A
    Life Sci; 1997; 60(19):1699-708. PubMed ID: 9129125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isobolographic analysis of analgesic interactions between intrathecally and intracerebroventricularly administered fentanyl, morphine and D-Ala2-D-Leu5-enkephalin in morphine-tolerant and nontolerant mice.
    Roerig SC; Hoffman RG; Takemori AE; Wilcox GL; Fujimoto JM
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1091-9. PubMed ID: 1646321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of spinal mu opioid receptors in the development of morphine tolerance and dependence.
    DeLander GE; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1984 Oct; 231(1):91-6. PubMed ID: 6092607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single icv injection of KCl induces a selective and long-lasting inhibition of opioid analgesia in mice.
    Garzón J; Sánchez-Blázquez P
    NIDA Res Monogr; 1986; 75():450-3. PubMed ID: 2828991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delta opiate receptors mediate tail-shock induced antinociception at supraspinal levels.
    Watkins LR; Wiertelak EP; Maier SF
    Brain Res; 1992 Jun; 582(1):10-21. PubMed ID: 1323369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
    Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain.
    Rashid MH; Inoue M; Toda K; Ueda H
    J Pharmacol Exp Ther; 2004 Apr; 309(1):380-7. PubMed ID: 14718584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulators of pain in the spinal cord.
    Jen MF; Lu CH; Huang L; Han JS
    NIDA Res Monogr; 1986; 75():457-60. PubMed ID: 2893278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of adenosine in antinociception produced by spinal or supraspinal receptor-selective opioid agonists: dissociation from gastrointestinal effects in mice.
    DeLander GE; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1097-104. PubMed ID: 1335055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
    Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.